Publications by authors named "Beverley Shields"

Claim this Profile
V
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study.
Laura M Güdemann, Katherine G Young, Pedro Cardoso, Bilal A Mateen, Rury R Holman, Beverley M Shields

Lancet Reg Health Eur· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.
Thijs T Jansz, Katherine G Young, Rhian Hopkins, Andrew P McGovern, Beverley M Shields

Diabetologia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triangulating Instrumental Variable, confounder adjustment and difference-in-difference methods for comparative effectiveness research in observational data.
Laura M Güdemann, John M Dennis, Andrew P McGovern, Lauren R Rodgers, Beverley M Shields

Wellcome Open Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updating a Clinical Prediction Model for Identifying Monogenic Diabetes to Include Both Clinical Features and Biomarkers.
Julieanne Knupp, Pedro Cardoso, Katherine G Young, Timothy J McDonald, Kashyap A Patel, Beverley M Shields

Diabetes Care· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study.
Jean Claude Katte, Steven Squires, Mesmin Y Dehayem, Priscilla A Balungi, Carolyn J Padoa, Beverley M Shields

Lancet Diabetes Endocrinol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.
Pedro Cardoso, Katie G Young, Rhian Hopkins, Bilal A Mateen, Ewan R Pearson, Beverley M Shields

Diabetes Obes Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA reliability.
Anxious J Niwaha, Priscilla A Balungi, Timothy J McDonald, Andrew T Hattersley, Beverley M Shields

Diabet Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth.
Guido Alarcon, Anh Nguyen, Angus Jones, Beverley Shields, Maria J Redondo

J Clin Endocrinol Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can 4 weeks of real-world active breaks improve glycaemic management in sedentary adults with type 1 diabetes? The EXTOD-Active randomised control trial protocol.
Joseph G Jenkins, Matthew Cocks, Parth Narendran, Robert C Andrews, Beverley M Shields

BMJ Open Sport Exerc Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study.
Anxious J Niwaha, Beverley M Shields, Lauren R Rodgers, Andrew T Hattersley, Robert C Andrews

Diabet Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study.
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, Angus G Jones, Andrew T Hattersley, Beverley M Shields

Diabetes Obes Metab· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.
John M Dennis, Katherine G Young, Pedro Cardoso, Laura M Güdemann, Andrew P McGovern, Beverley M Shields

Lancet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes.
Raymond J Kreienkamp, Beverley M Shields, Toni I Pollin, Amy S Shah, Angela D Liese

Diabetes Care· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study.
Angus G Jones, Beverley M Shields, Richard A Oram, Dana M Dabelea, William A Hagopian

Diabetes Care· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
Laura M Güdemann, Katie G Young, Nicholas J M Thomas, Rhian Hopkins, Robert Challen, Beverley M Shields

Diabetologia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.
Pedro Cardoso, Katie G Young, Andrew T Hattersley, Beverley M Shields, Angus G Jones

Diabetes Care· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of haemoglobin variants on the diagnostic sensitivity of glycated haemoglobin (HbA1c) assay methodologies in sub-Saharan Africa: a laboratory-based method validation study.
Priscilla Agatha Balungi, Anxious Jackson Niwaha, Rachel Nice, Lauren Rodgers, Nathan Mubiru, Beverley Shields

Pan Afr Med J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.
Pedro Cardoso, Timothy J McDonald, Kashyap A Patel, Ewan R Pearson, Andrew T Hattersley, Beverley M Shields

BMC Med Res Methodol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.
Pedro Cardoso, Katie G Young, Anand T N Nair, Rhian Hopkins, Andrew P McGovern, Beverley M Shields

Diabetologia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis.
Beverley M Shields, Annelie Carlsson, Kashyap Patel, Julieanne Knupp, Akaal Kaur

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of European prediction models for classification of type 1 and type 2 diabetes in Indians.
Ulagamadesan Venkatesan, Anandakumar Amutha, Angus G Jones, Beverley M Shields, Ranjit Mohan Anjana

Diabetes Metab Syndr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy.
Pedro Cardoso, John M Dennis, Jack Bowden, Beverley M Shields, Trevelyan J McKinley

BMC Med Inform Decis Mak· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, James Godwin, Daniyal Raja, Beverley M Shields

BMJ Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy.
Katherine G Young, Rhian Hopkins, Beverley M Shields, Nicholas J Thomas, Andrew P McGovern

Cardiovasc Diabetol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical prediction models combining routine clinical measures identify participants with youth-onset diabetes who maintain insulin secretion in the range associated with type 2 diabetes: The SEARCH for Diabetes in Youth Study.
Angus G Jones, Beverley M Shields, Richard A Oram, Dana M Dabelea, William A Hagopian

medRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis